Related Experiment Video
Updated: Mar 26, 2026

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
Antidepressant treatment response: 'I want it all, and I want it now!'†
Gin S Malhi1, Anne R Lingford-Hughes2, Allan H Young2
1Gin S. Malhi, Professor and Chair of Psychiatry, and Associate Director Kolling Institute, University of Sydney, Australia; Anne R. Lingford-Hughes, Professor of Addiction Biology, Centre for Neuropsychopharmacology, Division of Brain Sciences, Department of Medicine, Imperial College London, UK; Allan H. Young, Chair of Mood Disorders and Director of Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK gin.malhi@sydney.edu.au.
Abstract:
The treatment of depression remains suboptimal, highlighting the need for more effective antidepressants. Traditional drug discovery and development is time-consuming and costly, prompting the need for faster translation of novel therapies into practice. But clinical expediency comes at a cost against which potential benefits need to be considered judiciously.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Psychosis: Goals of Pharmacotherapy
Electroconvulsive Therapy
Drug Therapy
Antianxiety Medications

